DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
13.83B
Enterprise Value 3
18.68B
Trailing P/E
19.36
Forward P/E 1
15.12
PEG Ratio (5 yr expected) 1
2.89
Price/Sales (ttm)
1.83
Price/Book (mrq)
2.54
Enterprise Value/Revenue 3
2.47
Enterprise Value/EBITDA 6
12.61

Trading Information

Stock Price History

Beta (3Y Monthly) 0.85
52-Week Change 32.18%
S&P500 52-Week Change 38.32%
52 Week High 3107.97
52 Week Low 378.95
50-Day Moving Average 3104.69
200-Day Moving Average 399.86

Share Statistics

Avg Vol (3 month) 3922.25k
Avg Vol (10 day) 3640.64k
Shares Outstanding 5134.67M
Float 133.98M
% Held by Insiders 10.35%
% Held by Institutions 191.55%
Shares Short (Sep 30, 2019) 43.94M
Short Ratio (Sep 30, 2019) 44.4
Short % of Float (Sep 30, 2019) 43.31%
Short % of Shares Outstanding (Sep 30, 2019) 42.93%
Shares Short (prior month Aug 30, 2019) 43.92M

Dividends & Splits

Forward Annual Dividend Rate 42.12
Forward Annual Dividend Yield 42.00%
Trailing Annual Dividend Rate 32.09
Trailing Annual Dividend Yield 32.00%
5 Year Average Dividend Yield 41.93
Payout Ratio 440.50%
Dividend Date 3Oct 21, 2019
Ex-Dividend Date 4Oct 3, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 21, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 9.64%
Operating Margin (ttm)15.29%

Management Effectiveness

Return on Assets (ttm)6.43%
Return on Equity (ttm)13.93%

Income Statement

Revenue (ttm)7.57B
Revenue Per Share (ttm)56.09
Quarterly Revenue Growth (yoy)1.80%
Gross Profit (ttm)2.67B
EBITDA 1.48B
Net Income Avi to Common (ttm)707M
Diluted EPS (ttm)5.30
Quarterly Earnings Growth (yoy)3.20%

Balance Sheet

Total Cash (mrq)273M
Total Cash Per Share (mrq)2.03
Total Debt (mrq)4.57B
Total Debt/Equity (mrq)81.86
Current Ratio (mrq)0.82
Book Value Per Share (mrq)40.44

Cash Flow Statement

Operating Cash Flow (ttm)1.29B
Levered Free Cash Flow (ttm)616.37M